InvestorsHub Logo
Followers 4
Posts 1330
Boards Moderated 0
Alias Born 01/01/2007

Re: corwatcher post# 34194

Wednesday, 08/18/2010 3:38:40 PM

Wednesday, August 18, 2010 3:38:40 PM

Post# of 51855
It's ironic: Tran is going to Eurhythmics to develop novel antidepressants (here comes the rain again...) on the strength of his track record at Lilly, where he helped bring to market 2 antidepressants (Prozac Cymbalta), which the press-release itself states have been found to be ineffective in 66% of the patients who take them.

Onwards and upwards.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News